Panitumumab

In the US, Panitumumab (panitumumab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer.

US matches:

• Panitumumab


• Panitumumab Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XC08

CAS registry number (Chemical Abstracts Service)

0339177-26-3

Chemical Formula

C6398-H9878-N1694-O2016-S48

Molecular Weight

142346

Therapeutic Categories

Antineoplastic agent

Immunomodulator

Monoclonal antibody

Chemical Names

Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer (WHO)

Immunoglobulin, human (anti-human epidermal growth factor receptor) monoclonal antibody (ABX-EGF)

Foreign Names

• Panitumumabum (Latin)
• Panitumumab (German)
• Panitumumab (French)
• Panitumumab (Spanish)

Generic Names

• ABX-EGF MAb (IS)
• anti-EGFr MAb (IS)
• rHuMAB-EGFr (IS)

Brand Names

• Vectibix
  Amgen, Austria; Amgen, Australia; Amgen, Belgium; Amgen, Canada; Amgen, Germany; Amgen, Spain; Amgen, United Kingdom; Amgen, Ireland; Amgen, Luxembourg; Amgen, Netherlands; Amgen, Norway; Amgen, Sweden; Amgen, Slovenia; Amgen, Slovakia; Amgen, United States; Amgen Switzerland, Switzerland; Amgen Europe B.VNL, Denmark

International Drug Name Search

Glossary

IS	Inofficial Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.